权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Structural and Biochemical Basis of the Vitamin K cycle

维生素 K 循环的结构和生化基础

基本信息

批准号：
7714059
负责人：
Weikai Li
金额：
$ 9万
依托单位：
HARVARD MEDICAL SCHOOL
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-01 至 2011-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7714059
关键词：
Acids Address Allergens Amino Acids Animals Anticoagulants Area Asthma Award Binding Biochemical Bioinformatics Biological Assay Blood Coagulation Factor Blood Vessels Breathing Calcium ion Catalysis Chronic Complex Coumarins Coupled Couples Culture Techniques Cysteine Deep Vein Thrombosis Dendritic Cells Disease Electron Transport Electrons Enzymes Epithelial Epithelial Cells Epithelium Future Genetic Genetic Predisposition to Disease Goals Hemorrhage High Pressure Liquid Chromatography Homologous Gene Human Hydroquinones Inbred Strains Mice Inflammatory Laboratories Lead Lung Lung diseases Maps Mediating Medical Membrane Membrane Proteins Mentors Methods Modeling Molecular Conformation Mus Mutagenesis Mutation Myelogenous Myocardial Infarction Oral Pancreatic ribonuclease Pathology Pathway interactions Peptides Periplasmic Proteins Pharmaceutical Preparations Phase Population Principal Investigator Production Protein Disulfide Isomerase Protein translocation Proteins Publishing Pulmonary Embolism Quinones Reaction Recombinants Research Research Personnel Resolution Role Scientist Series Staging Stroke Structure Surface Susceptibility Gene Synechococcus T-Lymphocyte Th2 Cells Therapeutic Thioredoxin Thrombosis Training Universities Vitamin K Vitamins Warfarin Work airway hyperresponsiveness alpha benzopyrone base carboxylation career career development cofactor cytokine density design drug mechanism electron density electron donor epoxidase gamma-glutamyl carboxylase high risk hydroquinone improved inhibitor/antagonist mutant novel periplasm prevent reduced vitamin K research study resistance mutation response sample fixation skills tool vitamin K epoxide reductase vitamin K1 oxide

项目摘要

DESCRIPTION (provided by applicant): Asthma is a chronic inflammatory disease of the lung thought to be mediated exclusively by the products of Th2 cells. Preliminary evidence suggests that genetic susceptibility to allergen-induced airway hyperresponsiveness (AHR) results from differential epithelial cell responsiveness to inhaled allergen. In susceptible animals, epithelial cell-derived factors selectively enhance the activation, and production of Th17-skewing cytokines by pulmonary myeloid dendritic cells (mDC). However, it is unclear how the epithelium enhances mDC capacity to promote Th17 responses, or how Th17 and Th2 cells collaborate to exacerbate asthma. The aims are: 1) to identify the epithelial cell factors responsible for promoting the activation of pulmonary mDCs, 2) identify the role of Th17 responses in exacerbating the Th2-associated pathology, and 3) identify novel asthma susceptibility genes using a novel tool, recombinant inbred mouse strains from the Collaborative Cross. The studies and career development activities outlined in this proposal will allow the candidate to achieve his long term career goal of becoming an independent investigator with a focus on dissecting how genetic differences influence the ability of epithelial cells to regulate dendritic cell activity, and promote Th17 T cell responses. To acquire the necessary skill set, the candidate's K99 research will take place in the lab of Marsha Wills-Karp, an expert in the field of asthma genetics, and pulmonary epithelial culture techniques, where he will acquire expertise in the culture and manipulation of murine pulmonary epithelium. Moreover, during the mentored phase, the candidate will acquire expertise in the use of genetic and bioinformatics approaches to identify novel asthma susceptibility genes, through advanced training at the University of Cincinnati, and Jackson Laboratories. This training will be essential for completing the research proposed for the independent phase of this award. Subsequent studies to dissect the function of identified asthma susceptibility genes in murine and human populations will form the basis of future R01 applications, assisting in the transition to scientific independence.

描述（由申请人提供）：哮喘是一种慢性炎症性肺病，被认为仅由Th 2细胞产物介导。初步证据表明，过敏原诱导的气道高反应性（AHR）的遗传易感性是由于上皮细胞对吸入过敏原的不同反应性。在易感动物中，上皮细胞衍生因子选择性地增强肺髓样树突状细胞（mDC）的活化和Th 17-偏斜细胞因子的产生。然而，目前尚不清楚上皮细胞如何增强mDC促进Th 17应答的能力，或者Th 17和Th 2细胞如何合作加剧哮喘。其目标是：1）鉴定负责促进肺mDC活化的上皮细胞因子，2）鉴定Th 17应答在加剧Th 2相关病理中的作用，和3）使用新工具，来自协作杂交的重组近交小鼠品系，鉴定新的哮喘易感基因。本提案中概述的研究和职业发展活动将使候选人实现其长期职业目标，即成为一名独立的研究者，重点是剖析遗传差异如何影响上皮细胞调节树突状细胞活性的能力，并促进Th 17 T细胞反应。为了获得必要的技能，候选人的K99研究将在玛莎·威尔斯-卡普（Marsha Wills-Karp）的实验室进行，他是哮喘遗传学和肺上皮细胞培养技术领域的专家，在那里他将获得培养和操纵K99的专业知识。小鼠肺上皮此外，在指导阶段，候选人将获得专业知识，在使用遗传和生物信息学方法，以确定新的哮喘易感基因，通过在辛辛那提大学和杰克逊实验室的高级培训。这项培训对于完成该奖项独立阶段的研究至关重要。随后的研究，以剖析功能的确定哮喘易感基因在小鼠和人类群体将形成未来的R 01应用的基础，协助过渡到科学的独立性。